Vistapath
1 known investors
Vistapath develops the Sentinel platform, an AI-powered system for automated tissue grossing used in pathology laboratories. It serves clinical and diagnostic labs to support pathology digitization, precision, and workflow efficiency.
Investors Β· 1
Founder mafia
2 people who came through Vistapath went on to found or lead other companies.
Frequently asked questions
- What does Vistapath do?
- Vistapath develops the Sentinel platform, an AI-powered system for automated tissue grossing used in pathology laboratories. It serves clinical and diagnostic labs to support pathology digitization, precision, and workflow efficiency.
- Who are Vistapath's investors?
- Vistapath's investors include Walnut Venture Associates.